Concepedia

Changpu Yu

CY

Statistics

Publications

15

Citations

2K

H-Index

13

Active since

2000

Affiliations

Seagen (United States)(Current)

University of Washington

Target (United States)

Celltechgen (United States)

Fred Hutch Cancer Center

Changpu Yu is an author at Seagen (United States) specializing in medicine, pharmacology, and oncology.

Publications per year

2000–2017

15

Publications

15

SGN-CD33A: a novel CD33-targeting antibody–drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML

May S.K. Sutherland, Roland B. Walter, Scott C. Jeffrey et al. · Blood · 2013 · 386 citations

, , +13

Lysosomal Trafficking and Cysteine Protease Metabolism Confer Target-specific Cytotoxicity by Peptide-linked Anti-CD30-Auristatin Conjugates

May S.K. Sutherland, Russell J. Sanderson, Kristine A. Gordon et al. · Journal of Biological Chemistry · 2006 · 296 citations · Full text

, , +16

Impaired Preneoplastic Changes and Liver Tumor Formation in Tumor Necrosis Factor Receptor Type 1 Knockout Mice

Belinda Knight, George C. Yeoh, Kirsten L. Husk et al. · The Journal of Experimental Medicine · 2000 · 295 citations · Full text

, , +16

Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation

May Kung Sutherland, James C. Geoghegan, Changpu Yu et al. · Bone · 2004 · 239 citations

, , +14

Establishment, Characterization, and Long–Term Maintenance of Cultures of Human Fetal Hepatocytes

Catherine A. Lázaro, Emma Croager, Claudia Mitchell et al. · Hepatology · 2003 · 185 citations · Full text

, , +15

1–5 of 15